Pharmazeutische Erzeugnisse-Aktien
Vollständige Übersicht aller 257 börsennotierten Unternehmen der Branche Pharmazeutische Erzeugnisse. Vergleichen Sie Marktkapitalisierung, Bewertungs-KGV, Dividendenrendite und Insider-Scores im direkten Wettbewerbsvergleich.
Die Branche Pharmazeutische Erzeugnisse im Sektor Gesundheit umfasst aktuell 257 börsennotierte US-Unternehmen mit einer aggregierten Marktkapitalisierung von 6,06 Bio. $. Gemessen an der Marktkapitalisierung wird die Branche von ELI LILLY & Co (LLY), JOHNSON & JOHNSON (JNJ), BeOne Medicines Ltd. (ONC) angeführt. Mit einem Median-KGV von 20,0 spiegelt die Branche das Bewertungsniveau im Sektor Gesundheit wider. Die höchsten quantitativen Insider- und Conviction-Scores weisen aktuell EXEL (Score 74) sowie AZN (Score 74) auf. Klicken Sie auf ein beliebiges Unternehmen, um dessen vollständige SEC-Form-4-Meldungen, Eigentümerstruktur und Peer-Group-Matrix zu analysieren.
| # | Unternehmen / Ticker | Marktkapitalisierung | Letzter Kurs | KGV | Dividende | Insider-Score | Analyse |
|---|---|---|---|---|---|---|---|
| 1 | LLY ELI LILLY & Co | 1,22 Bio. $ Mega Cap | 1.273,46 $ | 56,9 | 0,5 % | 68 | Details › |
| 2 | JNJ JOHNSON & JOHNSON | 620,6 Mrd. $ Mega Cap | 263,81 $ | 23,9 | 2,0 % | 57 | Details › |
| 3 | ONC BeOne Medicines Ltd. | 511,5 Mrd. $ Mega Cap | 373,33 $ | 1.964,9 | — | 37 | Details › |
| 4 | ABBV AbbVie Inc. | 500,0 Mrd. $ Mega Cap | 286,47 $ | 121,4 | 2,3 % | 65 | Details › |
| 5 | MRK Merck & Co., Inc. | 370,2 Mrd. $ Mega Cap | 145,27 $ | 20,2 | 2,2 % | 67 | Details › |
| 6 | NVS NOVARTIS AG | 290,4 Mrd. $ Mega Cap | 151,12 $ | 21,6 | 2,8 % | 56 | Details › |
| 7 | AZN ASTRAZENECA PLC | 263,1 Mrd. $ Mega Cap | 171,49 $ | 26,1 | 1,8 % | 74 | Details › |
| 8 | AMGN AMGEN INC | 242,0 Mrd. $ Mega Cap | 439,26 $ | 31,4 | 2,2 % | 60 | Details › |
| 9 | GILD GILEAD SCIENCES, INC. | 197,8 Mrd. $ Mega Cap | 156,04 $ | 23,2 | 2,0 % | 61 | Details › |
| 10 | PFE PFIZER INC | 174,3 Mrd. $ Mega Cap | 29,87 $ | 22,0 | 5,7 % | 60 | Details › |
| 11 | NVO NOVO NORDISK A S | 173,5 Mrd. $ Mega Cap | 39,05 $ | 1,7 | 3,5 % | 65 | Details › |
| 12 | VRTX VERTEX PHARMACEUTICALS INC / MA | 129,8 Mrd. $ Mega Cap | 523,93 $ | 34,9 | — | 51 | Details › |
| 13 | BMY BRISTOL MYERS SQUIBB CO | 129,1 Mrd. $ Mega Cap | 61,48 $ | 18,2 | 3,9 % | 69 | Details › |
| 14 | CSLLY CSL LTD | 123,2 Mrd. $ Mega Cap | 34,59 $ | — | 3,5 % | 39 | Details › |
| 15 | GSK GSK plc | 102,4 Mrd. $ Mega Cap | 50,75 $ | 18,1 | 3,2 % | 61 | Details › |
| 16 | REGN REGENERON PHARMACEUTICALS, INC. | 88,1 Mrd. $ Mega Cap | 805,02 $ | 19,7 | — | 66 | Details › |
| 17 | MRNA Moderna, Inc. | 71,4 Mrd. $ Mega Cap | 196,42 $ | — | — | 26 | Details › |
| 18 | TAK TAKEDA PHARMACEUTICAL CO LTD | 64,0 Mrd. $ Mega Cap | 20,53 $ | 0,3 | 3,1 % | 69 | Details › |
| 19 | ARGX ARGENX SE | 52,5 Mrd. $ Mega Cap | 873,15 $ | 41,4 | — | 51 | Details › |
| 20 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | 46,9 Mrd. $ Mega Cap | 39,41 $ | 33,2 | — | 57 | Details › |
| 21 | HLN Haleon plc | 43,8 Mrd. $ Mega Cap | 10,20 $ | 28,0 | 1,7 % | 48 | Details › |
| 22 | BIIB BIOGEN INC. | 37,3 Mrd. $ Mega Cap | 250,69 $ | 28,9 | — | 66 | Details › |
| 23 | KVUE Kenvue Inc. | 35,6 Mrd. $ Mega Cap | 19,50 $ | 25,7 | 4,5 % | 64 | Details › |
| 24 | ZTS Zoetis Inc. | 32,2 Mrd. $ Mega Cap | 80,31 $ | 13,3 | 2,6 % | 64 | Details › |
| 25 | ALNY ALNYLAM PHARMACEUTICALS, INC. | 29,6 Mrd. $ Mega Cap | 224,83 $ | 96,5 | — | 50 | Details › |
| 26 | FUJIY FUJI PHOTO FILM CO LTD /FI | 25,9 Mrd. $ Mega Cap | 10,76 $ | 0,1 | 2,5 % | 50 | Details › |
| 27 | ZLAB Zai Lab Ltd | 24,4 Mrd. $ Mega Cap | 24,16 $ | — | — | 32 | Details › |
| 28 | UTHR UNITED THERAPEUTICS Corp | 24,1 Mrd. $ Mega Cap | 587,50 $ | 21,0 | — | 59 | Details › |
| 29 | INCY INCYTE CORP | 23,6 Mrd. $ Mega Cap | 115,71 $ | 18,2 | — | 58 | Details › |
| 30 | INSM INSMED Inc | 21,0 Mrd. $ Mega Cap | 93,39 $ | — | — | 31 | Details › |
| 31 | VTRS Viatris Inc | 19,6 Mrd. $ Mega Cap | 18,38 $ | — | 2,8 % | 69 | Details › |
| 32 | EXEL EXELIXIS, INC. | 15,2 Mrd. $ Mega Cap | 64,53 $ | 23,5 | — | 74 | Details › |
| 33 | ASND Ascendis Pharma A/S | 14,5 Mrd. $ Mega Cap | 245,31 $ | — | — | 61 | Details › |
| 34 | NBIX NEUROCRINE BIOSCIENCES INC | 14,3 Mrd. $ Mega Cap | 142,70 $ | 30,7 | — | 68 | Details › |
| 35 | JAZZ Jazz Pharmaceuticals plc | 13,9 Mrd. $ Mega Cap | 214,00 $ | — | — | 49 | Details › |
| 36 | SMMT Summit Therapeutics Inc. | 12,0 Mrd. $ Mega Cap | 14,62 $ | — | — | 39 | Details › |
| 37 | CORT CORCEPT THERAPEUTICS INC | 11,7 Mrd. $ Mega Cap | 85,86 $ | 131,1 | — | 51 | Details › |
| 38 | BMRN BIOMARIN PHARMACEUTICAL INC | 11,0 Mrd. $ Mega Cap | 55,95 $ | 31,5 | — | 45 | Details › |
| 39 | RDY DR REDDYS LABORATORIES LTD | 10,9 Mrd. $ Mega Cap | 13,60 $ | 0,3 | 0,6 % | 49 | Details › |
| 40 | ELAN Elanco Animal Health Inc | 10,8 Mrd. $ Mega Cap | 22,77 $ | — | — | 58 | Details › |
| 41 | MDGL MADRIGAL PHARMACEUTICALS, INC. | 10,6 Mrd. $ Mega Cap | 434,24 $ | — | — | 39 | Details › |
| 42 | CYTK CYTOKINETICS INC | 8,7 Mrd. $ Large Cap | 61,23 $ | — | — | 31 | Details › |
| 43 | TGTX TG THERAPEUTICS, INC. | 8,2 Mrd. $ Large Cap | 54,17 $ | 19,2 | — | 47 | Details › |
| 44 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | 8,0 Mrd. $ Large Cap | 58,02 $ | — | — | 42 | Details › |
| 45 | ALKS Alkermes plc. | 7,1 Mrd. $ Large Cap | 44,18 $ | 30,9 | — | 74 | Details › |
| 46 | IONS IONIS PHARMACEUTICALS INC | 7,0 Mrd. $ Large Cap | 42,93 $ | — | — | 30 | Details › |
| 47 | LNTH Lantheus Holdings, Inc. | 6,5 Mrd. $ Large Cap | 99,99 $ | 29,3 | — | 71 | Details › |
| 48 | AMRX Amneal Pharmaceuticals, Inc. | 6,4 Mrd. $ Large Cap | 21,08 $ | 95,8 | — | 41 | Details › |
| 49 | ABVX Abivax S.A. | 6,2 Mrd. $ Large Cap | 86,62 $ | — | — | 51 | Details › |
| 50 | IMVT Immunovant, Inc. | 6,1 Mrd. $ Large Cap | 28,21 $ | — | — | 36 | Details › |
| 51 | GRFS Grifols SA | 6,1 Mrd. $ Large Cap | 7,93 $ | 14,0 | 2,2 % | 63 | Details › |
| 52 | KNSA Kiniksa Pharmaceuticals International, plc | 6,1 Mrd. $ Large Cap | 72,01 $ | 96,0 | — | 57 | Details › |
| 53 | RYTM RHYTHM PHARMACEUTICALS, INC. | 5,9 Mrd. $ Large Cap | 89,64 $ | — | — | 51 | Details › |
| 54 | BLTE BELITE BIO, INC | 5,9 Mrd. $ Large Cap | 143,31 $ | — | — | 30 | Details › |
| 55 | LGND LIGAND PHARMACEUTICALS INC | 5,9 Mrd. $ Large Cap | 303,53 $ | 50,2 | — | 67 | Details › |
| 56 | MANE Veradermics, Inc | 5,8 Mrd. $ Large Cap | 137,39 $ | — | — | 57 | Details › |
| 57 | MIRM Mirum Pharmaceuticals, Inc. | 5,1 Mrd. $ Large Cap | 82,68 $ | — | — | 41 | Details › |
| 58 | PTCT PTC THERAPEUTICS, INC. | 5,0 Mrd. $ Large Cap | 60,59 $ | 8,1 | — | 74 | Details › |
| 59 | ERAS Erasca, Inc. | 4,9 Mrd. $ Large Cap | 15,10 $ | — | — | 39 | Details › |
| 60 | DFTX Definium Therapeutics, Inc. | 4,8 Mrd. $ Large Cap | 35,57 $ | — | — | 59 | Details › |
| 61 | AMRN AMARIN CORP PLC\UK | 4,8 Mrd. $ Large Cap | 11,79 $ | — | — | 68 | Details › |
| 62 | TVTX Travere Therapeutics, Inc. | 4,7 Mrd. $ Large Cap | 49,56 $ | — | — | 41 | Details › |
| 63 | GPCR Structure Therapeutics Inc. | 4,6 Mrd. $ Large Cap | 21,09 $ | — | — | 33 | Details › |
| 64 | INDV Indivior Pharmaceuticals, Inc. | 4,1 Mrd. $ Large Cap | 34,47 $ | 21,0 | — | 48 | Details › |
| 65 | OGN Organon & Co. | 3,6 Mrd. $ Large Cap | 13,75 $ | 19,1 | 2,5 % | 62 | Details › |
| 66 | ARQT Arcutis Biotherapeutics, Inc. | 3,5 Mrd. $ Large Cap | 31,72 $ | — | — | 49 | Details › |
| 67 | ACAD ACADIA PHARMACEUTICALS INC | 3,3 Mrd. $ Large Cap | 19,73 $ | 8,8 | — | 52 | Details › |
| 68 | TLX Telix Pharmaceuticals Ltd | 3,1 Mrd. $ Large Cap | 9,15 $ | — | — | 35 | Details › |
| 69 | TARS Tarsus Pharmaceuticals, Inc. | 3,0 Mrd. $ Large Cap | 69,74 $ | — | — | 36 | Details › |
| 70 | AMLX Amylyx Pharmaceuticals, Inc. | 2,9 Mrd. $ Large Cap | 26,73 $ | — | — | 59 | Details › |
| 71 | LQDA Liquidia Corp | 2,8 Mrd. $ Large Cap | 44,52 $ | — | — | 28 | Details › |
| 72 | HCM HUTCHMED (China) Ltd | 2,5 Mrd. $ Large Cap | 14,34 $ | 5,4 | — | 61 | Details › |
| 73 | SUPN SUPERNUS PHARMACEUTICALS, INC. | 2,5 Mrd. $ Large Cap | 40,01 $ | — | — | 46 | Details › |
| 74 | PBH Prestige Consumer Healthcare Inc. | 2,4 Mrd. $ Large Cap | 47,99 $ | 12,3 | — | 58 | Details › |
| 75 | NAMS NewAmsterdam Pharma Co N.V. | 2,4 Mrd. $ Large Cap | 19,54 $ | — | — | 27 | Details › |
| 76 | ADMA ADMA BIOLOGICS, INC. | 2,3 Mrd. $ Large Cap | 10,99 $ | 18,3 | — | 64 | Details › |
| 77 | PHVS Pharvaris N.V. | 2,3 Mrd. $ Large Cap | 31,64 $ | — | — | 57 | Details › |
| 78 | BHC Bausch Health Companies Inc. | 2,2 Mrd. $ Large Cap | 6,44 $ | 15,5 | — | 49 | Details › |
| 79 | AUPH Aurinia Pharmaceuticals Inc. | 2,2 Mrd. $ Large Cap | 17,03 $ | 8,2 | — | 63 | Details › |
| 80 | IMNM Immunome Inc. | 2,0 Mrd. $ Large Cap | 17,80 $ | — | — | 34 | Details › |
| 81 | HRMY Harmony Biosciences Holdings, Inc. | 2,0 Mrd. $ Mid Cap | 36,46 $ | 13,5 | — | 48 | Details › |
| 82 | BCRX BIOCRYST PHARMACEUTICALS INC | 2,0 Mrd. $ Mid Cap | 7,65 $ | 6,4 | — | 64 | Details › |
| 83 | XERS Xeris Biopharma Holdings, Inc. | 1,9 Mrd. $ Mid Cap | 10,21 $ | — | — | 43 | Details › |
| 84 | TRVI Trevi Therapeutics, Inc. | 1,9 Mrd. $ Mid Cap | 12,48 $ | — | — | 43 | Details › |
| 85 | PVLA PALVELLA THERAPEUTICS, INC. | 1,9 Mrd. $ Mid Cap | 126,23 $ | — | — | 34 | Details › |
| 86 | AGIO AGIOS PHARMACEUTICALS, INC. | 1,8 Mrd. $ Mid Cap | 37,52 $ | — | — | 41 | Details › |
| 87 | SRPT Sarepta Therapeutics, Inc. | 1,8 Mrd. $ Mid Cap | 17,73 $ | — | — | 45 | Details › |
| 88 | URGN UroGen Pharma Ltd. | 1,8 Mrd. $ Mid Cap | 34,19 $ | — | — | 36 | Details › |
| 89 | NVAX NOVAVAX INC | 1,8 Mrd. $ Mid Cap | 9,70 $ | 3,9 | — | 24 | Details › |
| 90 | ANIP ANI PHARMACEUTICALS INC | 1,6 Mrd. $ Mid Cap | 72,61 $ | 22,2 | — | 59 | Details › |
| 91 | ALVO Alvotech | 1,6 Mrd. $ Mid Cap | 4,62 $ | 46,2 | — | 57 | Details › |
| 92 | KLRA Kailera Therapeutics, Inc. | 1,6 Mrd. $ Mid Cap | 12,85 $ | — | — | 49 | Details › |
| 93 | OCUL OCULAR THERAPEUTIX, INC | 1,6 Mrd. $ Mid Cap | 6,56 $ | — | — | 25 | Details › |
| 94 | PAHC PHIBRO ANIMAL HEALTH CORP | 1,6 Mrd. $ Mid Cap | 38,80 $ | 16,4 | 1,2 % | 57 | Details › |
| 95 | ETON Eton Pharmaceuticals, Inc. | 1,5 Mrd. $ Mid Cap | 50,97 $ | — | — | 45 | Details › |
| 96 | INVA Innoviva, Inc. | 1,5 Mrd. $ Mid Cap | 20,66 $ | 6,4 | — | 71 | Details › |
| 97 | STOK Stoke Therapeutics, Inc. | 1,5 Mrd. $ Mid Cap | 25,02 $ | — | — | 41 | Details › |
| 98 | AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL | 1,5 Mrd. $ Mid Cap | 15,44 $ | — | — | 32 | Details › |
| 99 | RARE Ultragenyx Pharmaceutical Inc. | 1,5 Mrd. $ Mid Cap | 15,97 $ | — | — | 33 | Details › |
| 100 | PCRX Pacira BioSciences, Inc. | 1,4 Mrd. $ Mid Cap | 36,44 $ | 227,7 | — | 71 | Details › |
| 101 | NBTX Nanobiotix S.A. | 1,4 Mrd. $ Mid Cap | 31,61 $ | — | — | 33 | Details › |
| 102 | AVLN Avalyn Pharma Inc. | 1,3 Mrd. $ Mid Cap | 27,14 $ | — | — | 51 | Details › |
| 103 | SNDX Syndax Pharmaceuticals Inc | 1,2 Mrd. $ Mid Cap | 13,58 $ | — | — | 27 | Details › |
| 104 | AMPH Amphastar Pharmaceuticals, Inc. | 1,1 Mrd. $ Mid Cap | 25,39 $ | 12,5 | — | 65 | Details › |
| 105 | SPTX Seaport Therapeutics, Inc. | 1,1 Mrd. $ Mid Cap | 20,61 $ | — | — | 48 | Details › |
| 106 | HROW HARROW, INC. | 1,0 Mrd. $ Mid Cap | 28,87 $ | — | — | 39 | Details › |
| 107 | MNKD MANNKIND CORP | 974,0 Mio. $ Mid Cap | 3,19 $ | 160,0 | — | 44 | Details › |
| 108 | HELP Helus Pharma Inc. | 934,6 Mio. $ Mid Cap | 10,36 $ | — | — | 46 | Details › |
| 109 | SVRA Savara Inc | 921,5 Mio. $ Mid Cap | 4,34 $ | — | — | 27 | Details › |
| 110 | CGEM Cullinan Therapeutics, Inc. | 917,8 Mio. $ Mid Cap | 14,63 $ | — | — | 60 | Details › |
| 111 | SGP SpyGlass Pharma, Inc. | 917,5 Mio. $ Mid Cap | 29,91 $ | — | — | 40 | Details › |
| 112 | AVBP ArriVent BioPharma, Inc. | 906,7 Mio. $ Mid Cap | 15,33 $ | — | — | 38 | Details › |
| 113 | GLUE Monte Rosa Therapeutics, Inc. | 896,2 Mio. $ Mid Cap | 10,38 $ | — | — | 30 | Details › |
| 114 | KURA Kura Oncology, Inc. | 871,0 Mio. $ Mid Cap | 9,75 $ | — | — | 44 | Details › |
| 115 | ANRO Alto Neuroscience, Inc. | 859,2 Mio. $ Mid Cap | 22,11 $ | — | — | 53 | Details › |
| 116 | PHAR Pharming Group N.V. | 831,8 Mio. $ Mid Cap | 11,90 $ | 297,5 | — | — | Details › |
| 117 | CRVS Corvus Pharmaceuticals, Inc. | 830,4 Mio. $ Mid Cap | 10,56 $ | — | — | 46 | Details › |
| 118 | APMD Apnimed, Inc. | 763,1 Mio. $ Mid Cap | 18,99 $ | — | — | — | Details › |
| 119 | VSTM Verastem, Inc. | 748,3 Mio. $ Mid Cap | 9,91 $ | — | — | 40 | Details › |
| 120 | GERN GERON CORP | 732,1 Mio. $ Mid Cap | 1,12 $ | — | — | 40 | Details › |
| 121 | COLL COLLEGIUM PHARMACEUTICAL, INC | 725,8 Mio. $ Mid Cap | 23,14 $ | 13,4 | — | 60 | Details › |
| 122 | GYRE GYRE THERAPEUTICS, INC. | 715,3 Mio. $ Mid Cap | 5,77 $ | 288,5 | — | 51 | Details › |
| 123 | ACHV ACHIEVE LIFE SCIENCES, INC. | 648,4 Mio. $ Mid Cap | 6,49 $ | — | — | 42 | Details › |
| 124 | LXRX LEXICON PHARMACEUTICALS, INC. | 638,5 Mio. $ Mid Cap | 1,42 $ | — | — | 41 | Details › |
| 125 | NVCT Nuvectis Pharma, Inc. | 623,1 Mio. $ Mid Cap | 18,46 $ | — | — | 46 | Details › |
| 126 | ZVRA ZEVRA THERAPEUTICS, INC. | 613,6 Mio. $ Mid Cap | 9,76 $ | 7,2 | — | 51 | Details › |
| 127 | CRMD CorMedix Inc. | 597,9 Mio. $ Mid Cap | 7,91 $ | 3,9 | — | 70 | Details › |
| 128 | AQST Aquestive Therapeutics, Inc. | 584,1 Mio. $ Mid Cap | 3,99 $ | — | — | 43 | Details › |
| 129 | IRWD IRONWOOD PHARMACEUTICALS INC | 564,7 Mio. $ Mid Cap | 3,50 $ | 23,3 | — | 45 | Details › |
| 130 | ANNX Annexon, Inc. | 510,8 Mio. $ Mid Cap | 3,78 $ | — | — | 39 | Details › |
| 131 | OCS Oculis Holding AG | 488,5 Mio. $ Mid Cap | 7,96 $ | — | — | 35 | Details › |
| 132 | EOLS Evolus, Inc. | 466,5 Mio. $ Mid Cap | 7,12 $ | — | — | 53 | Details › |
| 133 | KMDA KAMADA LTD | 445,4 Mio. $ Mid Cap | 7,84 $ | 22,4 | 3,0 % | 62 | Details › |
| 134 | RZLT Rezolute, Inc. | 427,0 Mio. $ Mid Cap | 3,78 $ | — | — | 58 | Details › |
| 135 | SPRY ARS Pharmaceuticals, Inc. | 402,5 Mio. $ Mid Cap | 4,03 $ | — | — | 34 | Details › |
| 136 | AVIR Atea Pharmaceuticals, Inc. | 378,3 Mio. $ Mid Cap | 4,24 $ | — | — | 46 | Details › |
| 137 | FENC FENNEC PHARMACEUTICALS INC. | 348,6 Mio. $ Mid Cap | 10,08 $ | — | — | 40 | Details › |
| 138 | IRD Opus Genetics, Inc. | 314,8 Mio. $ Mid Cap | 3,47 $ | — | — | 37 | Details › |
| 139 | EBS Emergent BioSolutions Inc. | 312,9 Mio. $ Mid Cap | 6,30 $ | 6,8 | — | 58 | Details › |
| 140 | TTRX Turn Therapeutics Inc. | 299,3 Mio. $ Small Cap | 10,28 $ | — | — | 50 | Details › |
| 141 | XFOR X4 Pharmaceuticals, Inc | 295,3 Mio. $ Small Cap | 3,20 $ | — | — | 45 | Details › |
| 142 | QNRX Quoin Pharmaceuticals Ltd. | 290,9 Mio. $ Small Cap | 4,15 $ | — | — | 38 | Details › |
| 143 | FULC Fulcrum Therapeutics, Inc. | 277,7 Mio. $ Small Cap | 3,67 $ | — | — | 35 | Details › |
| 144 | ELTP ELITE PHARMACEUTICALS INC /NV/ | 271,6 Mio. $ Small Cap | 0,25 $ | 8,3 | — | 52 | Details › |
| 145 | VNDA Vanda Pharmaceuticals Inc. | 254,5 Mio. $ Small Cap | 4,06 $ | — | — | 34 | Details › |
| 146 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | 240,0 Mio. $ Small Cap | 6,40 $ | — | — | 42 | Details › |
| 147 | ACB AURORA CANNABIS INC | 238,8 Mio. $ Small Cap | 3,90 $ | — | — | 59 | Details › |
| 148 | MREO Mereo BioPharma Group plc | 232,9 Mio. $ Small Cap | 0,28 $ | — | — | 41 | Details › |
| 149 | TLSI TriSalus Life Sciences, Inc. | 232,4 Mio. $ Small Cap | 3,63 $ | — | — | 60 | Details › |
| 150 | EYPT EyePoint, Inc. | 231,1 Mio. $ Small Cap | 0,40 $ | — | — | 38 | Details › |
| 151 | GLSI Greenwich LifeSciences, Inc. | 227,5 Mio. $ Small Cap | 16,38 $ | — | — | 30 | Details › |
| 152 | SLGL Sol-Gel Technologies Ltd. | 226,0 Mio. $ Small Cap | 70,90 $ | — | — | 39 | Details › |
| 153 | SIGA SIGA TECHNOLOGIES INC | 222,7 Mio. $ Small Cap | 3,12 $ | 9,8 | 19,4 % | 54 | Details › |
| 154 | MGNX MACROGENICS INC | 222,6 Mio. $ Small Cap | 2,09 $ | — | — | 32 | Details › |
| 155 | PLX Protalix BioTherapeutics, Inc. | 221,7 Mio. $ Small Cap | 2,55 $ | — | — | 50 | Details › |
| 156 | BBOT BridgeBio Oncology Therapeutics, Inc. | 212,1 Mio. $ Small Cap | 2,64 $ | — | — | 32 | Details › |
| 157 | IFRX InflaRx N.V. | 209,5 Mio. $ Small Cap | 1,59 $ | — | — | 58 | Details › |
| 158 | ACOG Alpha Cognition Inc. | 199,8 Mio. $ Small Cap | 8,30 $ | — | — | 51 | Details › |
| 159 | ALEC Alector, Inc. | 191,8 Mio. $ Small Cap | 1,89 $ | — | — | 36 | Details › |
| 160 | ELDN Eledon Pharmaceuticals, Inc. | 190,0 Mio. $ Small Cap | 2,29 $ | — | — | 51 | Details › |
| 161 | AKBA Akebia Therapeutics, Inc. | 179,4 Mio. $ Small Cap | 0,67 $ | — | — | 53 | Details › |
| 162 | IVVD Invivyd, Inc. | 168,5 Mio. $ Small Cap | 0,60 $ | — | — | 37 | Details › |
| 163 | CHRS Coherus Oncology, Inc. | 164,2 Mio. $ Small Cap | 1,00 $ | 0,7 | — | 36 | Details › |
| 164 | ZNTL Zentalis Pharmaceuticals, Inc. | 162,9 Mio. $ Small Cap | 2,11 $ | — | — | 44 | Details › |
| 165 | OTLK Outlook Therapeutics, Inc. | 145,7 Mio. $ Small Cap | 0,50 $ | — | — | 15 | Details › |
| 166 | NGEN NERVGEN PHARMA CORP. | 144,2 Mio. $ Small Cap | 1,42 $ | — | — | 55 | Details › |
| 167 | MDWD MediWound Ltd. | 141,6 Mio. $ Small Cap | 12,03 $ | — | — | 45 | Details › |
| 168 | DERM Journey Medical Corp | 136,6 Mio. $ Small Cap | 4,98 $ | — | — | 52 | Details › |
| 169 | CRDL Cardiol Therapeutics Inc. | 135,8 Mio. $ Small Cap | 1,14 $ | — | — | 44 | Details › |
| 170 | ANTX AN2 Therapeutics, Inc. | 132,1 Mio. $ Small Cap | 3,63 $ | — | — | 40 | Details › |
| 171 | CPIX CUMBERLAND PHARMACEUTICALS INC | 131,8 Mio. $ Small Cap | 8,49 $ | — | — | 72 | Details › |
| 172 | CUE Cue Biopharma, Inc. | 129,0 Mio. $ Small Cap | 18,59 $ | — | — | 35 | Details › |
| 173 | NERV Minerva Neurosciences, Inc. | 122,5 Mio. $ Small Cap | 2,24 $ | — | — | 37 | Details › |
| 174 | BGM BGM Group Ltd. | 114,9 Mio. $ Small Cap | 7,85 $ | — | — | — | Details › |
| 175 | MENS Jyong Biotech Ltd. | 106,5 Mio. $ Small Cap | 1,77 $ | — | — | — | Details › |
| 176 | NRXP NRX Pharmaceuticals, Inc. | 99,6 Mio. $ Small Cap | 2,51 $ | — | — | 29 | Details › |
| 177 | ICCC IMMUCELL CORP /DE/ | 98,1 Mio. $ Small Cap | 10,25 $ | — | — | — | Details › |
| 178 | TNXP Tonix Pharmaceuticals Holding Corp. | 94,3 Mio. $ Small Cap | 5,24 $ | — | — | 35 | Details › |
| 179 | LENZ LENZ Therapeutics, Inc. | 92,3 Mio. $ Small Cap | 3,17 $ | — | — | 27 | Details › |
| 180 | MIST Milestone Pharmaceuticals Inc. | 88,0 Mio. $ Small Cap | 0,65 $ | — | — | 39 | Details › |
| 181 | ZYBT Zhengye Biotechnology Holding Ltd | 87,7 Mio. $ Small Cap | 1,48 $ | — | — | — | Details › |
| 182 | VTVT vTv Therapeutics Inc. | 87,3 Mio. $ Small Cap | 25,88 $ | — | — | 43 | Details › |
| 183 | ACRV Acrivon Therapeutics, Inc. | 72,1 Mio. $ Small Cap | 1,74 $ | — | — | 60 | Details › |
| 184 | TELO Telomir Pharmaceuticals, Inc. | 71,7 Mio. $ Small Cap | 1,03 $ | — | — | — | Details › |
| 185 | PTHS Pelthos Therapeutics Inc. | 70,9 Mio. $ Small Cap | 17,00 $ | — | — | 27 | Details › |
| 186 | CTOR CITIUS ONCOLOGY, INC. | 70,8 Mio. $ Small Cap | 0,58 $ | — | — | — | Details › |
| 187 | PMVP PMV Pharmaceuticals, Inc. | 70,0 Mio. $ Small Cap | 1,18 $ | — | — | 36 | Details › |
| 188 | BMEA Biomea Fusion, Inc. | 66,8 Mio. $ Small Cap | 0,62 $ | — | — | 29 | Details › |
| 189 | SPRO Spero Therapeutics, Inc. | 64,6 Mio. $ Small Cap | 1,06 $ | 7,1 | — | 48 | Details › |
| 190 | RNTX Rein Therapeutics, Inc. | 63,9 Mio. $ Small Cap | 0,58 $ | — | — | 34 | Details › |
| 191 | VRCA Verrica Pharmaceuticals Inc. | 63,5 Mio. $ Small Cap | 3,64 $ | — | — | 41 | Details › |
| 192 | RTSN Retension Pharmaceuticals, Inc. | 62,7 Mio. $ Small Cap | 15,25 $ | — | — | — | Details › |
| 193 | TENX TENAX THERAPEUTICS, INC. | 60,1 Mio. $ Small Cap | 1,72 $ | — | — | 33 | Details › |
| 194 | TLPH TALPHERA, INC. | 54,5 Mio. $ Small Cap | 1,08 $ | — | — | — | Details › |
| 195 | CLNN Clene Inc. | 50,9 Mio. $ Small Cap | 3,82 $ | — | — | 41 | Details › |
| 196 | CNTB Connect Biopharma Holdings Ltd | 47,6 Mio. $ Micro Cap | 0,84 $ | — | — | 42 | Details › |
| 197 | YARW Yarrow Bioscience, Inc. | 44,7 Mio. $ Micro Cap | 19,62 $ | — | — | 29 | Details › |
| 198 | AARD Aardvark Therapeutics, Inc. | 42,0 Mio. $ Micro Cap | 1,08 $ | — | — | 46 | Details › |
| 199 | GRCE Grace Therapeutics, Inc. | 41,9 Mio. $ Micro Cap | 1,81 $ | — | — | 42 | Details › |
| 200 | MTNB Matinas BioPharma Holdings, Inc. | 41,4 Mio. $ Micro Cap | 1,58 $ | — | — | — | Details › |
| 201 | ATNM Actinium Pharmaceuticals, Inc. | 41,2 Mio. $ Micro Cap | 1,45 $ | — | — | 44 | Details › |
| 202 | ATHE ALTERITY THERAPEUTICS LTD | 40,2 Mio. $ Micro Cap | 2,09 $ | — | — | — | Details › |
| 203 | NNVC NANOVIRICIDES, INC. | 35,6 Mio. $ Micro Cap | 1,38 $ | — | — | 48 | Details › |
| 204 | COSM Cosmos Health Inc. | 34,8 Mio. $ Micro Cap | 0,26 $ | — | — | 37 | Details › |
| 205 | IXHL Incannex Healthcare Inc. | 33,2 Mio. $ Micro Cap | 2,61 $ | — | — | 36 | Details › |
| 206 | CPHI CHINA PHARMA HOLDINGS, INC. | 31,0 Mio. $ Micro Cap | 0,66 $ | — | — | 46 | Details › |
| 207 | VBIO Valion Bio, Inc. | 28,7 Mio. $ Micro Cap | 0,78 $ | — | — | 10 | Details › |
| 208 | RMTI ROCKWELL MEDICAL, INC. | 27,7 Mio. $ Micro Cap | 6,94 $ | — | — | 48 | Details › |
| 209 | ABVC ABVC BIOPHARMA, INC. | 27,6 Mio. $ Micro Cap | 1,04 $ | — | — | — | Details › |
| 210 | IGC IGC Pharma, Inc. | 27,4 Mio. $ Micro Cap | 0,25 $ | — | — | 51 | Details › |
| 211 | NSRX Nasus Pharma Ltd | 27,4 Mio. $ Micro Cap | 3,49 $ | — | — | — | Details › |
| 212 | MIRA MIRA PHARMACEUTICALS, INC. | 26,1 Mio. $ Micro Cap | 0,53 $ | — | — | — | Details › |
| 213 | EDSA Edesa Biotech, Inc. | 25,5 Mio. $ Micro Cap | 2,69 $ | — | — | 37 | Details › |
| 214 | CNTX Context Therapeutics Inc. | 24,2 Mio. $ Micro Cap | 0,24 $ | — | — | 44 | Details › |
| 215 | ELAB PMGC Holdings Inc. | 21,5 Mio. $ Micro Cap | 2,66 $ | — | — | — | Details › |
| 216 | AYTU AYTU BIOPHARMA, INC | 21,5 Mio. $ Micro Cap | 1,90 $ | — | — | — | Details › |
| 217 | SCLX Scilex Holding Co | 20,5 Mio. $ Micro Cap | 2,28 $ | — | — | — | Details › |
| 218 | KYNB KYNTRA BIO, INC. | 20,4 Mio. $ Micro Cap | 4,58 $ | 0,1 | — | — | Details › |
| 219 | ATYR aTYR PHARMA INC | 18,6 Mio. $ Micro Cap | 0,16 $ | — | — | 33 | Details › |
| 220 | OPTH Optimi Health Corp. | 18,4 Mio. $ Micro Cap | 3,12 $ | — | — | — | Details › |
| 221 | KAPA Kairos Pharma, LTD. | 15,3 Mio. $ Micro Cap | 0,56 $ | — | — | 31 | Details › |
| 222 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | 15,1 Mio. $ Micro Cap | 4,94 $ | — | — | 26 | Details › |
| 223 | RKTO Rocket One Inc. | 14,5 Mio. $ Micro Cap | 0,54 $ | — | — | 34 | Details › |
| 224 | KPTI Karyopharm Therapeutics Inc. | 14,4 Mio. $ Micro Cap | 0,46 $ | — | — | 11 | Details › |
| 225 | CLRB Cellectar Biosciences, Inc. | 12,6 Mio. $ Micro Cap | 1,21 $ | — | — | 35 | Details › |
| 226 | BFRI Biofrontera Inc. | 12,3 Mio. $ Micro Cap | 0,80 $ | — | — | 37 | Details › |
| 227 | CNSY CERENOME, INC. | 12,3 Mio. $ Micro Cap | 1,54 $ | — | — | 30 | Details › |
| 228 | CTXR Citius Pharmaceuticals, Inc. | 12,0 Mio. $ Micro Cap | 0,41 $ | — | — | — | Details › |
| 229 | ASBP Aspire-Lakewood Holdings, Inc. | 11,6 Mio. $ Micro Cap | 8,15 $ | — | — | 36 | Details › |
| 230 | AEON AEON Biopharma, Inc. | 11,3 Mio. $ Micro Cap | 0,24 $ | — | — | — | Details › |
| 231 | PHIO Phio Pharmaceuticals Corp. | 10,2 Mio. $ Micro Cap | 0,85 $ | — | — | — | Details › |
| 232 | TPST Tempest Therapeutics, Inc. | 10,2 Mio. $ Micro Cap | 0,52 $ | — | — | 19 | Details › |
| 233 | ADIL ADIAL PHARMACEUTICALS, INC. | 10,0 Mio. $ Micro Cap | 3,64 $ | — | — | — | Details › |
| 234 | ENSC Ensysce Biosciences, Inc. | 9,4 Mio. $ Micro Cap | 0,45 $ | — | — | 29 | Details › |
| 235 | BFRG BullFrog AI Holdings, Inc. | 8,4 Mio. $ Micro Cap | 0,49 $ | — | — | 26 | Details › |
| 236 | JAGX Jaguar Health, Inc. | 6,3 Mio. $ Micro Cap | 2,33 $ | — | — | 1 | Details › |
| 237 | ENVB Enveric Biosciences, Inc. | 6,1 Mio. $ Micro Cap | 1,40 $ | — | — | — | Details › |
| 238 | APUS Apimeds Pharmaceuticals US, Inc. | 6,0 Mio. $ Micro Cap | 2,89 $ | — | — | 24 | Details › |
| 239 | ACXP Acurx Pharmaceuticals, Inc. | 5,8 Mio. $ Micro Cap | 1,11 $ | — | — | — | Details › |
| 240 | TRAW Traws Pharma, Inc. | 5,8 Mio. $ Micro Cap | 0,34 $ | 0,4 | — | — | Details › |
| 241 | MGRX MANGOCEUTICALS, INC. | 5,6 Mio. $ Micro Cap | 0,24 $ | — | — | 19 | Details › |
| 242 | AIM AIM ImmunoTech Inc. | 4,9 Mio. $ Micro Cap | 0,16 $ | — | — | — | Details › |
| 243 | CVKD Cadrenal Therapeutics, Inc. | 3,4 Mio. $ Micro Cap | 0,93 $ | — | 1.726,3 % | — | Details › |
| 244 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | 3,1 Mio. $ Micro Cap | 0,87 $ | — | — | — | Details › |
| 245 | UPC Universe Pharmaceuticals INC | 2,8 Mio. $ Micro Cap | 3,22 $ | — | — | — | Details › |
| 246 | JUNS JUPITER NEUROSCIENCES, INC. | 2,3 Mio. $ Micro Cap | 2,98 $ | — | — | — | Details › |
| 247 | PPCB Propanc Biopharma, Inc. | 2,3 Mio. $ Micro Cap | 2,41 $ | — | — | — | Details › |
| 248 | RADX Radiopharm Theranostics Ltd | 1,7 Mio. $ Micro Cap | 1,01 $ | — | — | — | Details › |
| 249 | ONCO Onconetix, Inc. | 1,6 Mio. $ Micro Cap | 0,42 $ | — | — | 24 | Details › |
| 250 | ATPC Agape ATP Corp | 1,5 Mio. $ Micro Cap | 1,40 $ | — | — | — | Details › |
| 251 | RDHL RedHill Biopharma Ltd. | 1,4 Mio. $ Micro Cap | 0,42 $ | — | — | — | Details › |
| 252 | LABT Lakewood-Amedex Biotherapeutics Inc. | 1,2 Mio. $ Micro Cap | 0,31 $ | — | — | — | Details › |
| 253 | CMND Clearmind Medicine Inc. | 1,1 Mio. $ Micro Cap | 5,94 $ | — | — | — | Details › |
| 254 | EDVA Endovia Health Sciences, Inc. | 943.879 $ Micro Cap | 0,16 $ | — | — | — | Details › |
| 255 | IMCC IM Cannabis Corp. | 498.248 $ Micro Cap | 0,84 $ | — | — | — | Details › |
| 256 | PBM PSYENCE BIOMEDICAL LTD. | 98.065 $ Micro Cap | 3,66 $ | — | — | 34 | Details › |
| 257 | SXTC China SXT Pharmaceuticals, Inc. | 13.860 $ Micro Cap | 3,58 $ | — | — | — | Details › |
Ersteller: Verantwortlich für Erstellung und Verbreitung ist der Betreiber dieser Website (siehe Impressum). Die Einstufung wird arbeitstäglich automatisiert neu berechnet.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in besprochenen Werten halten. Methodik: Methodik und Datenquellen.